Ultra-minimally invasive prostate dilation for BPH symptoms
Part of Kidney & urinary clinical trials.
This study tests a new, minimally invasive procedure to relieve urinary symptoms caused by an enlarged prostate (benign prostatic hyperplasia or BPH). The procedure gently dilates (widens) the prostate to improve urine flow and reduce bothersome symptoms like frequent urination and weak stream.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male aged 40–80 years
- You have moderate-to-severe urinary symptoms from an enlarged prostate (IPSS score of 13 or higher)
- Your peak urine flow rate is between 5–10 mL/s, and you void at least 150 mL per time
- Your prostate volume is less than 30 mL on ultrasound
- You have normal sexual function and a sexual partner
- You can commit to follow-up visits and avoid sexual activity for 90 days after the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two minimally invasive procedures to relieve urinary symptoms caused by an enlarged prostate. Both treatments aim to open the urethra without major surgery, and the goal is to improve your urine flow and reduce bothersome symptoms.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.
This study tracks the outcomes of various minimally invasive procedures for an enlarged prostate that causes urinary symptoms. It aims to learn which treatments work best for different patients.
This study compares two minimally invasive procedures that remove extra prostate tissue to help with urination problems. It may help if other treatments haven't worked.
This trial tests a device called Optilume BPH Catheter System for men with enlarged prostate that causes bothersome urinary symptoms. It aims to see how safe and effective it is in real-world use, offering a possible treatment for blocked urine flow without surgery.
Hear when a new BPH (Benign Prostatic Hyperplasia) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.